Edenbrook Capital, Llc Purchases 12,581 Shares of Marchex, Inc. (NASDAQ:MCHX) Stock

Marchex, Inc. (NASDAQ:MCHX) major shareholder Edenbrook Capital, Llc bought 12,581 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was purchased at an average cost of $3.97 per share, for a total transaction of $49,946.57. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Edenbrook Capital, Llc also recently made the following trade(s):

  • On Friday, November 29th, Edenbrook Capital, Llc acquired 7,300 shares of Marchex stock. The shares were bought at an average cost of $4.00 per share, for a total transaction of $29,200.00.
  • On Wednesday, November 27th, Edenbrook Capital, Llc acquired 10,119 shares of Marchex stock. The shares were bought at an average cost of $3.97 per share, for a total transaction of $40,172.43.
  • On Thursday, November 14th, Edenbrook Capital, Llc acquired 41,400 shares of Marchex stock. The shares were bought at an average cost of $4.15 per share, for a total transaction of $171,810.00.
  • On Tuesday, November 12th, Edenbrook Capital, Llc acquired 20,600 shares of Marchex stock. The shares were bought at an average cost of $4.13 per share, for a total transaction of $85,078.00.
  • On Thursday, November 7th, Edenbrook Capital, Llc acquired 100,000 shares of Marchex stock. The shares were bought at an average cost of $3.78 per share, for a total transaction of $378,000.00.
  • On Thursday, October 24th, Edenbrook Capital, Llc acquired 1,677 shares of Marchex stock. The shares were bought at an average cost of $3.07 per share, for a total transaction of $5,148.39.
  • On Monday, October 14th, Edenbrook Capital, Llc bought 215 shares of Marchex stock. The shares were acquired at an average price of $3.07 per share, for a total transaction of $660.05.
  • On Thursday, October 10th, Edenbrook Capital, Llc bought 200 shares of Marchex stock. The shares were acquired at an average price of $3.04 per share, for a total transaction of $608.00.
  • On Thursday, October 3rd, Edenbrook Capital, Llc bought 5,332 shares of Marchex stock. The shares were acquired at an average price of $3.05 per share, for a total transaction of $16,262.60.
  • On Tuesday, October 1st, Edenbrook Capital, Llc bought 2,500 shares of Marchex stock. The shares were acquired at an average price of $3.10 per share, for a total transaction of $7,750.00.

Shares of MCHX stock traded down $0.04 during mid-day trading on Wednesday, reaching $3.92. 115,464 shares of the company’s stock traded hands, compared to its average volume of 129,217. Marchex, Inc. has a 12 month low of $2.51 and a 12 month high of $5.57. The company has a market cap of $173.23 million, a P/E ratio of -65.33 and a beta of 1.56. The company has a quick ratio of 4.28, a current ratio of 4.28 and a debt-to-equity ratio of 0.06. The company’s 50-day moving average price is $3.62 and its 200-day moving average price is $3.93.

Marchex (NASDAQ:MCHX) last announced its earnings results on Wednesday, November 6th. The technology company reported ($0.02) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.04) by $0.02. The firm had revenue of $24.79 million for the quarter, compared to analysts’ expectations of $24.05 million. Marchex had a negative net margin of 4.24% and a negative return on equity of 0.58%. Equities analysts predict that Marchex, Inc. will post -0.05 earnings per share for the current year.

A number of analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Marchex from a “hold” rating to a “buy” rating and set a $3.50 target price on the stock in a report on Wednesday, October 9th. ValuEngine upgraded shares of Marchex from a “sell” rating to a “hold” rating in a report on Friday, November 8th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $5.83.

A number of institutional investors have recently made changes to their positions in MCHX. Tower Research Capital LLC TRC bought a new position in Marchex in the 2nd quarter worth about $45,000. AMP Capital Investors Ltd bought a new position in Marchex in the 2nd quarter worth about $62,000. Cubist Systematic Strategies LLC bought a new position in Marchex in the 2nd quarter worth about $92,000. Stone Ridge Asset Management LLC bought a new position in Marchex in the 2nd quarter worth about $114,000. Finally, Rhumbline Advisers boosted its stake in Marchex by 15.3% in the 3rd quarter. Rhumbline Advisers now owns 37,895 shares of the technology company’s stock worth $119,000 after purchasing an additional 5,022 shares in the last quarter. Institutional investors own 55.49% of the company’s stock.

About Marchex

Marchex, Inc operates as a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. Its products include Marchex Call Analytics, an analytics platform for enterprises that depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Speech Analytics that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, which enable businesses to send and receive text/SMS messages with customers; Call Monitoring; Marchex Omnichannel Analytics Cloud products, such as Marchex Search Analytics, a product for search marketers that drive phone calls from search campaigns, as well as Marchex Display and Video Analytics, a product for marketers that buy digital display advertising; Marchex Site Analytics, a product for marketers that can drive phone calls from Websites; and Marchex Social Analytics, a product for marketers that buy social media advertising.

Read More: How to Invest in Stocks with Increasing Dividends

Insider Buying and Selling by Quarter for Marchex (NASDAQ:MCHX)

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.